Actinogen Limited

ASX:ACW ISIN:AU000000ACW3

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12108

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article▸
###

1,470 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 18) (Since Published: 1470) 

Company Data

More News Results

  • 2024/04/22: ACW completes cognition & depression phase 2 trial enrolment*
  • 2024/04/15: First patient treated in ACW XanaMIA ph 2b Alzheimers trial*
  • 2024/04/15: Notification of cessation of securities - ACW*
  • 2024/04/05: Appendix 3Y-Mr Malcolm McComas*
  • 2024/04/05: Notification of cessation of securities - ACW*
  • 2024/04/03: Application for quotation of securities - ACW*
  • 2024/03/25: ACW corporate presentation revised licensing slide*
  • 2024/03/20: Notification of buy-back - ACW*
  • 2024/03/20: Actinogen corporate presentation March 2024*
  • 2024/03/07: Application for quotation of securities - ACW*
*refer to company website